INKT logo

MiNK Therapeutics (INKT) Cash From Investing

Annual CFI

-$73.60 K
+$176.40 K+70.56%

December 31, 2023


Summary


Performance

INKT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINKTcash flowmetrics:

Quarterly CFI

$0.00
$0.000.00%

September 30, 2024


Summary


Performance

INKT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINKTcash flowmetrics:

TTM CFI

$0.00
+$23.00 K+100.00%

September 30, 2024


Summary


Performance

INKT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINKTcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

INKT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+70.6%0.0%0.0%
3 y3 years+22.7%0.0%0.0%
5 y5 years+82.7%0.0%0.0%

INKT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+70.6%-100.0%+100.0%at high+100.0%
5 y5-yearat high+82.7%-100.0%+100.0%at high+100.0%
alltimeall timeat high+82.7%-100.0%+100.0%at high+100.0%

MiNK Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2024
-
$0.00(0.0%)
-$23.00 K(-61.7%)
Mar 2024
-
$0.00(0.0%)
-$60.00 K(-18.4%)
Dec 2023
-$73.60 K(-70.6%)
$0.00(-100.0%)
-$73.50 K(-63.5%)
Sep 2023
-
-$23.00 K(-37.8%)
-$201.30 K(-15.5%)
Jun 2023
-
-$37.00 K(+174.1%)
-$238.10 K(-9.6%)
Mar 2023
-
-$13.50 K(-89.4%)
-$263.50 K(+5.4%)
Dec 2022
-$250.00 K
-$127.80 K(+113.7%)
-$250.00 K(+105.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$59.80 K(-4.2%)
-$121.90 K(-29.9%)
Jun 2022
-
-$62.40 K(<-9900.0%)
-$173.90 K(-17.0%)
Mar 2022
-
$0.00(-100.0%)
-$209.40 K(-15.9%)
Dec 2021
-$249.00 K(+161.6%)
$300.00(-100.3%)
-$248.90 K(-0.1%)
Sep 2021
-
-$111.80 K(+14.2%)
-$249.20 K(+81.4%)
Jun 2021
-
-$97.90 K(+147.8%)
-$137.40 K(+247.8%)
Mar 2021
-
-$39.50 K
-$39.50 K
Dec 2020
-$95.20 K(-77.7%)
-
-
Dec 2019
-$426.50 K
-
-

FAQ

  • What is MiNK Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for MiNK Therapeutics?
  • What is MiNK Therapeutics annual CFI year-on-year change?
  • What is MiNK Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for MiNK Therapeutics?
  • What is MiNK Therapeutics quarterly CFI year-on-year change?
  • What is MiNK Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for MiNK Therapeutics?
  • What is MiNK Therapeutics TTM CFI year-on-year change?

What is MiNK Therapeutics annual cash flow from investing activities?

The current annual CFI of INKT is -$73.60 K

What is the all time high annual CFI for MiNK Therapeutics?

MiNK Therapeutics all-time high annual cash flow from investing activities is -$73.60 K

What is MiNK Therapeutics annual CFI year-on-year change?

Over the past year, INKT annual cash flow from investing activities has changed by +$176.40 K (+70.56%)

What is MiNK Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of INKT is $0.00

What is the all time high quarterly CFI for MiNK Therapeutics?

MiNK Therapeutics all-time high quarterly cash flow from investing activities is $300.00

What is MiNK Therapeutics quarterly CFI year-on-year change?

Over the past year, INKT quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is MiNK Therapeutics TTM cash flow from investing activities?

The current TTM CFI of INKT is $0.00

What is the all time high TTM CFI for MiNK Therapeutics?

MiNK Therapeutics all-time high TTM cash flow from investing activities is $0.00

What is MiNK Therapeutics TTM CFI year-on-year change?

Over the past year, INKT TTM cash flow from investing activities has changed by $0.00 (0.00%)